Kastelan S - Search Results

1

Inverse Levels of Adiponectin in Type 1 and Type 2 Diabetes Are in Accordance with the State of Albuminuria.

Ljubic S, Jazbec A, Tomic M, Piljac A, Jurisic Erzen D, Novak B, Kastelan S, Lovrencic MV, Brkljacic N. Ljubic S, et al. Among authors: kastelan s. Int J Endocrinol. 2015;2015:372796. doi: 10.1155/2015/372796. Epub 2015 May 18. Int J Endocrinol. 2015. PMID: 26089882 Free PMC article.

2

Maternal immune system adaptation to pregnancy--a potential influence on the course of diabetic retinopathy.

Kaštelan S, Tomić M, Pavan J, Orešković S. Kaštelan S, et al. Reprod Biol Endocrinol. 2010 Oct 21;8:124. doi: 10.1186/1477-7827-8-124. Reprod Biol Endocrinol. 2010. PMID: 20964838 Free PMC article.

3

The role of inflammation and endothelial dysfunction in the pathogenesis of diabetic retinopathy.

Tomić M, Ljubić S, Kastelan S. Tomić M, et al. Among authors: kastelan s. Coll Antropol. 2013 Apr;37 Suppl 1:51-7. Coll Antropol. 2013. PMID: 23837221

4

The association between the HLA system and retinopathy development in patients with type 1 diabetes mellitus.

Kastelan S, Tomić M, Salopek-Rabatić J, Pavan J, Lukenda A, Gotovac M, Zunec R. Kastelan S, et al. Coll Antropol. 2013 Apr;37 Suppl 1:65-70. Coll Antropol. 2013. PMID: 23837223

5

Influence of BAK-preserved prostaglandin analog treatment on the ocular surface health in patients with newly diagnosed primary open-angle glaucoma.

Tomić M, Kaštelan S, Soldo KM, Salopek-Rabatić J. Tomić M, et al. Among authors: kastelan s. Biomed Res Int. 2013;2013:603782. doi: 10.1155/2013/603782. Epub 2013 Jul 18. Biomed Res Int. 2013. PMID: 23971041 Free PMC article. Clinical Trial.

6

Diagnostic procedures and management of dry eye.

Kaštelan S, Tomić M, Salopek-Rabatić J, Novak B. Kaštelan S, et al. Biomed Res Int. 2013;2013:309723. doi: 10.1155/2013/309723. Epub 2013 Aug 19. Biomed Res Int. 2013. PMID: 24024186 Free PMC article. Review.

7

How ocular surface disease impacts the glaucoma treatment outcome.

Kaštelan S, Tomić M, Metež Soldo K, Salopek-Rabatić J. Kaštelan S, et al. Biomed Res Int. 2013;2013:696328. doi: 10.1155/2013/696328. Epub 2013 Oct 9. Biomed Res Int. 2013. PMID: 24224176 Free PMC article. Review.

8

Inflammation and pharmacological treatment in diabetic retinopathy.

Kaštelan S, Tomić M, Gverović Antunica A, Salopek Rabatić J, Ljubić S. Kaštelan S, et al. Mediators Inflamm. 2013;2013:213130. doi: 10.1155/2013/213130. Epub 2013 Oct 28. Mediators Inflamm. 2013. PMID: 24288441 Free PMC article. Review.

9

Body mass index: a risk factor for retinopathy in type 2 diabetic patients.

Kaštelan S, Tomić M, Gverović Antunica A, Ljubić S, Salopek Rabatić J, Karabatić M. Kaštelan S, et al. Mediators Inflamm. 2013;2013:436329. doi: 10.1155/2013/436329. Epub 2013 Nov 20. Mediators Inflamm. 2013. PMID: 24347825 Free PMC article.

10

Inflammation, haemostatic disturbance, and obesity: possible link to pathogenesis of diabetic retinopathy in type 2 diabetes.

Tomić M, Ljubić S, Kaštelan S, Gverović Antunica A, Jazbec A, Poljičanin T. Tomić M, et al. Among authors: kastelan s. Mediators Inflamm. 2013;2013:818671. doi: 10.1155/2013/818671. Epub 2013 Dec 2. Mediators Inflamm. 2013. PMID: 24363502 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page